CTOs on the Move

Nanoscope Therapeutics

www.nanostherapeutics.com

 
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Lifemark Health Group

We are a proudly Canadian healthcare company, providing diversified healthcare services across the country.

Vivo Infusion

Vivo Infusion is a leading provider of accessible, affordable, and safe community-based infusion and injection care for patients suffering from compromised immune systems, infectious diseases, and other medical conditions.

Phoenix Data Systems

Phoenix Data Systems, Inc. is a King Of Prussia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Futrix

Futrix is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Hospice of Southern Maine

Calling Hospice of Southern Maine doesn`t mean you`re giving up, it means you`re taking charge. At Hospice of Southern Maine, our mission is to provide compassion, care and comfort through the end of life for patients with a terminal illnesses and their families. We care for patients where they are, whether at home, in a long-term care and assisted living center, or at Gosnell Memorial Hospice House, our 18-bed facility in Scarborough.